Placental growth factor promotes epithelial-mesenchymal transition-like changes in ARPE-19 cells under hypoxia
Open Access
- 26 April 2018
- journal article
- research article
- Vol. 24, 340-352
Abstract
Purpose: To investigate the role of placental growth factor (PGF) in the epithelial-mesenchymal transition (EMT) of ARPE-19 cells under hypoxia, and whether the NF-kappa B signaling pathway is involved in this process. Methods: ARPE-19 cells were treated in five groups: a control group, hypoxia group, PGF group, hypoxia+PGF group, and NF-kappa B-blocked group. A chemical hypoxia model was established in the ARPE-19 cells by adding CoCl2 to the culture medium. The morphological changes after treatment were observed. The proliferation rates were measured with 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. The migration abilities were measured with scratch assay. The EMT biomarkers were measured with quantitative real-time PCR (qRT-PCR), western blotting, and immunofluorescence. The relative protein expression of components of the NF-kappa B signaling pathway was measured with western blotting and immunofluorescence. Results: Cells treated with PGF under hypoxia exhibited morphological changes consistent with the transition from an epithelial to a mesenchymal phenotype. In the ARPE-19 cells, exogenous PGF under hypoxia increased the proliferation rate compared to the rate under hypoxia alone (p<0.05) and increased the migration rate (p<0.05). Treatment of hypoxiaexposed cells with PGF caused decreased expression of the epithelial biomarkers E-cadherin and ZO-1 (both p<0.05) and increased expression of the mesenchymal marker alpha-SMA (p<0.05) by enhancing the phosphorylation of NF-kappa B p65 of the total protein, promoting the translocation of p65 to the nucleus, and inducing the degradation of I kappa B-alpha (a negative regulator of the NF-kappa B pathway) in the ARPE-19 cells. Additionally, the effect of PGF-induced EMT in the ARPE-19 cells under hypoxia was counteracted with BAY 11-7082 (a selective NF-kappa B inhibitor). Conclusions: Exogenous PGF promotes EMT-like changes in ARPE-19 cells under hypoxia by activating the NF-kappa B signaling pathway. The study results suggest that PGF may play a role in scar formation in neovascular age-related macular degeneration (AMD) and that the inhibition of PGF may be a promising target for the prevention and treatment of AMD.Keywords
This publication has 51 references indexed in Scilit:
- VEGF Receptor Blockade Markedly Reduces Retinal Microglia/Macrophage Infiltration into Laser-Induced CNVPLOS ONE, 2013
- Vascular Endothelial Growth Factor Receptor-1 Activation Promotes Migration and Invasion of Breast Cancer Cells through Epithelial-Mesenchymal TransitionPLOS ONE, 2013
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabAngiogenesis, 2012
- miR-200b is involved in intestinal fibrosis of Crohn’s diseaseInternational Journal of Molecular Medicine, 2012
- The discovery of placenta growth factor and its biological activityExperimental & Molecular Medicine, 2012
- PIGF Knockout Delays Brain Vessel Growth and Maturation upon Systemic Hypoxic ChallengeJournal of Cerebral Blood Flow & Metabolism, 2011
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- A systems view of epithelial–mesenchymal transition signaling statesClinical & Experimental Metastasis, 2010
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Common and unique mechanisms regulate fibrosis in various fibroproliferative diseasesJournal of Clinical Investigation, 2007